---
schema_version: "secwatch.filing_event.v1"
accession: "0001539497-22-001158"
form_type: "8-K"
ticker: "BIXT"
cik: "0001445815"
company_name: "BIOXYTRAN, INC"
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:42:28.346924+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bioxytran announces PCT publication of two COVID-19 treatment patents and USPTO trademark approval for ProLectin

## Summary
- PCT published patent WO 2022/099052 for polysaccharides treating SARS-CoV-2, filed Nov 2021.
- PCT published patent WO 2022/099061 for IV-administered pectin polysaccharides treating SARS-CoV-2.
- USPTO approved trademark 'ProLectin' for publication in Trademark Official Gazette on June 28, 2022.
- Both patents claim priority date of November 6, 2020.

## SEC filing metadata
- accession: 0001539497-22-001158
- form_type: 8-K
- ticker: BIXT
- cik: 0001445815
- company_name: BIOXYTRAN, INC
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1445815/000153949722001158/0001539497-22-001158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1445815/000153949722001158/n2583_x45-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001539497-22-001158
- JSON: https://secwatch.observer/filing/0001539497-22-001158.json
- Plain text: https://secwatch.observer/filing/0001539497-22-001158.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.